ALGEMENE BOUWONDERNEMING LEFEBVRE
NACE 41001 in Kortrijk · BE. Public registry data, filed financials, business card, and annual valuation trend on one indexed company profile.
ALGEMENE BOUWONDERNEMING LEFEBVRE
Valuation pending
The latest filing has no usable positive EBITDA or the sector multiple is not available yet.
No public range is shown here, but the page can still tell you what is usable, what is blocking the estimate, and which private evidence would make a defensible valuation possible.
About ALGEMENE BOUWONDERNEMING LEFEBVRE
ALGEMENE BOUWONDERNEMING LEFEBVRE is a business in NACE sector 41001 based in Kortrijk, Belgium. The company was founded in 1989, incorporated as a Besloten Vennootschap.
ALGEMENE BOUWONDERNEMING LEFEBVRE is listed in Belgian Crossroads Bank for Enterprises (KBO) under registry number 0438097134 and VAT number BE0438097134. This profile consolidates Brønnøysund, Companies House Profile, KBO registry, KvK registry, NBB/CBSO annual accounts, official annual accounts, Staatsbladmonitor public filings, Titan Official Financials into one indexable company dossier.
Within the Belgian NACE 41001 cluster, public-record data is filed annually via the national company registry.
Across the 2021-2024 window revenue has grown, moving from €40,195 to €59,638. EBITDA for 2024 comes in at €56,717.
The most recent annual filing covers 2024.
If you are researching ALGEMENE BOUWONDERNEMING LEFEBVRE for acquisition, investment, or due-diligence purposes, this page consolidates its firmographics, multi-year filings, and an indicative valuation into a single, citation-ready view.
Registered details
- Registry
- BE 0438097134
- VAT number
- BE0438097134
- Status
- active
- Founded
- 1989-07-25
- Legal form
- Besloten Vennootschap
- NACE
- 41001
- Address
- Bellegemsestraat(Bel) 166, 8510, Kortrijk
How this valuation is built
The valuation for ALGEMENE BOUWONDERNEMING LEFEBVRE combines official public company figures with Upswitch sector calibration. The owner can sharpen it with their own figures and context into a full, defensible valuation curve.